26
|
Kapuria D, Herndon B, Molteni A. Glucotoxicity Caused by Change in Hepatic Metabolic Pathways Leading to Type 2 Diabetes. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.767.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
27
|
Haldiman L, Glazyrin A, Herndon B, Kapuria D, Molteni A. Maspin Expression of Pancreatic Inflammation in an Obese Strain of Mice. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.767.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
28
|
Fletcher A, Raza F, Buursma J, Livingston S, Kearn D, Herndon B, Vanden Heauvel G, Baybutt R, Molteni A. Pathological Changes in the Heart of the Strain CUX1 Transgenic Mice. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.lb432] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
29
|
Kesh S, Buursma J, Livingston S, Kearn D, Dasari S, Herndon B, Vanden Heuvel G, Baybutt R, Molteni A. Smooth Muscle Actin (SMA1) Stain Lungs and Heart on a Strain of CUX‐1 Transgenic mice. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.lb439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
30
|
Hsiung I, Qin C, Poisner A, Herndon B, Quinn T, Molteni A. Renal Effect of Triolein in a Rat Model of Fat Embolism Syndrome. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.927.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
31
|
Helgeson S, Harris E, Herndon B, Vanden Heuvel G, Baybutt R, Molteni A. Incidence of Pulmonary Fibrosis in Lungs of CUX‐1 Transgenic Mice. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.411.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
32
|
Pelizzari A, Ferrero D, Molteni A, Allione B, Mezzabotta M, Clavio M, Borlenghi E, Rossi G, Masiera E, Santini V. 110 BIOSIMILAR EPOETIN ZETA FOR THE TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS). Leuk Res 2015. [DOI: 10.1016/s0145-2126(15)30111-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Naji D, Alqalyoobi S, Herndon B, Molteni A, Salzman G. Cardiac Damage in a Model of Pulmonary Fat Embolism. Chest 2014. [DOI: 10.1378/chest.1995023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
34
|
Alqalyoobi S, Naji D, Bass D, Herndon B, Molteni A, Salzman G. Angiotensin II Receptor Blocker Interrupts Persisting Lung Damage After Long Bone Trauma. Chest 2014. [DOI: 10.1378/chest.1990668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
35
|
Centis E, Trento M, Dei Cas A, Pontiroli AE, De Feo P, Bruno A, Sasdelli AS, Arturi F, Strollo F, Vigili De' Kreutzenberg S, Invitti C, Di Bonito P, Di Mauro M, Pugliese G, Molteni A, Marchesini G. Stage of change and motivation to healthy diet and habitual physical activity in type 2 diabetes. Acta Diabetol 2014; 51:559-66. [PMID: 24442514 DOI: 10.1007/s00592-013-0551-1] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2013] [Accepted: 12/19/2013] [Indexed: 10/25/2022]
Abstract
Lifestyle changes to healthy diet (HD) and habitual physical activity (HPA) are recommended in type 2 diabetes mellitus (T2DM). Yet, for most people with diabetes, it may be difficult to start changing. We investigated the stage of change toward healthier lifestyles according to Prochaska's model, and the associated psychological factors in T2DM patients, as a prerequisite to improve strategies to implement behavior changes in the population. A total of 1,353 consecutive outpatients with T2DM attending 14 tertiary centers for diabetes treatment completed the validated EMME-3 questionnaire, consisting of two parallel sets of instruments to define the stage of change for HD and HPA, respectively. Logistic regression was used to determine the factors associated with stages that may hinder behavioral changes. A stage of change favoring progress to healthier behaviors was more common in the area of HD than in HPA, with higher scores in action and maintenance. Differences were observed in relation to gender, age and duration of disease. After adjustment for confounders, resistance to change toward HD was associated with higher body mass index (BMI) (odds ratio (OR) 1.05; 95 % confidence interval (CI) 1.02-1.08). Resistance to improve HPA also increased with BMI (OR 1.06; 95 % CI 1.03-1.10) and decreased with education level (OR 0.74; 95 % CI 0.64-0.92). Changing lifestyle, particularly in the area of HPA, is not perceived as an essential part of treatment by many subjects with T2DM. This evidence must be considered when planning behavioral programs, and specific interventions are needed to promote adherence to HPA.
Collapse
|
36
|
Likhitsup A, Herndon B, Nachnani J, Alba L, Quinn T, Torres‐Romero L, Molteni A. Pancreatic damage in obese mice with liver steatosis: effects of Ω 3 fatty acid (909.1). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.909.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
37
|
Voelkel J, Harvey J, Adams J, Lassiter R, Stark M, Molteni A. FGF and Notch signaling hierarchy in sensory neurogenesis (651.18). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.651.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
38
|
Poisner A, Herndon B, Bass D, Jain A, Fletcher A, Molteni A. Losartan protects the lung from chronic cellular damage induced by fat embolism (LB512). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.lb512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
39
|
Molteni A, Saeed A, Glazyrin A, Pennington V, Gawlik M, Saeed A, Quinn T, Herndon B. Examining the carcinogenic potential of pancreatic inflammation in obese mice with maspin staining (1047.10). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.1047.10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
40
|
Harris E, Andres E, Jang I, Petrie A, Doo C, Safavi S, Herndon B, Vanden Heuvel G, Molteni A, Baybutt R. Pathological changes in the lungs of Cux1 transgenic mice (834.1). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.834.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
41
|
Ajemba O, Zia H, Lankachandra K, Singh G, Poisner A, Herndon B, Molteni A. Pulmonary histopathology of a case of fat embolism (FE) in a patient and its similarity to an animal model of FE (834.11). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.834.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
42
|
Likhitsup A, Alba L, Herndon B, Mansour A, Zia H, Molteni A. Histology of liver oxidative stress in an obese mouse model of nonalcoholic fatty liver disease treated with Ω3 fatty acids, TNFα‐receptor blocker, or curcumin (1116.1). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.1116.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
43
|
Fotouhi A, Fotouhi A, Boyer D, Herndon B, Quinn T, Molteni A. Nanoparticles in lungs: a model of effects after infection (406.3). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.406.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
44
|
Kesh S, Molteni A, Stevens T, Herndon B. The pulmonary vessel adventitia: role in the pathology of fat embolism (LB511). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.lb511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
45
|
Alkhazna A, Saeed A, Herndon B, Hilal A, Quinn T, Molteni A, Salzman G. The Renin-Angiotensin System [RAS] in Fat Embolism-Induced Lung Pathology. Chest 2013. [DOI: 10.1378/chest.1703841] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
46
|
Al Hariri A, Herndon B, Molteni A. Resistin: The Link From Fatty Inflammation to Macrophages. Chest 2013. [DOI: 10.1378/chest.1704483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
47
|
Greco R, Riva M, Ravano E, Molteni A, Morra E. P-299 Azacitidine in high-risk MDS patients. A “real life” experience from a single center. Leuk Res 2013. [DOI: 10.1016/s0145-2126(13)70346-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
48
|
Oliva E, Santini V, Zini G, Palumbo G, Poloni A, Cortelezzi A, Rodeghiero F, Voso M, Molteni A, Sanpaolo G, Liberati M, Morabito F, Balleari E, Impera S, Salvi F, Spiriti MA, Marino A, Rodà F, Alati C, Ronco F, Di Raimondo F, Leoni P, Alimena G, Latagliata R, Nobile F. P-310 Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: Results of a prospective, randomized trial. Leuk Res 2013. [DOI: 10.1016/s0145-2126(13)70357-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
49
|
Molteni A, Riva M, Ravano E, Greco R, Cesana C, Scarpati B, Morra E. P-099 The prognostic significance of the immunocytometric blast counts in MDS patients with medullar blasts <5% at the optical evaluation. Leuk Res 2013. [DOI: 10.1016/s0145-2126(13)70147-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
50
|
Molteni A, Torres‐Romero L, Black E, Friedrich J, Tanner JC, Poisner A, Herndon B. Fat Embolism Syndrome Following Bone Fracture May Be Exacerbated By LPS. FASEB J 2013. [DOI: 10.1096/fasebj.27.1_supplement.254.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|